Search
for
Sort by
Research 571–600 of 1000+
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- Contemporary medical therapy for polycystic ovary syndrome
- Contraception for Women with Polycystic Ovary Syndrome: Dealing with a Complex Condition
- The role of metformin in the management of polycystic ovary syndrome
- [Commentary] The Polyfollicular Anovulatory Androgenic Syndrome: A New Label for an Old Syndrome
- Correlation of clinical profile and anthropometry factors with free androgen index in evaluation of polycystic ovarian syndrome
- Эффективность комбинированных оральных контрацептивов у женщин с синдромом поликистозных яичников
- Aromatase deficiency in a male patient - Case report and review of the literature.
- Síndrome do ovário policístico: abordagem dermatológica
- Impact of systemic hormonal imbalances on sebaceous gland disorders: An in-depth review integrating clinical, endocrine, and therapeutic insights
- Testosterone alters iron metabolism and stimulates red blood cell production independently of dihydrotestosterone
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- The involvement of androgens in human hair growth
- The relationship among androgens, insulin resistanceand ghrelin polymorphisms in post-adolescent malepatients with severe acne vulgaris
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Testosterone Metabolism in the Skin
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Androgen receptor in rat liver: Characterization and separation from a male-specific estrogen-binding protein
- Bone vs. fat: Embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts
- The Effect of a Very-Low-Calorie Diet (VLCD) vs. a Moderate Energy Deficit Diet in Obese Women with Polycystic Ovary Syndrome (PCOS)—A Randomised Controlled Trial
- (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile, a potent androgen receptor antagonist for stimulating hair growth and reducing sebum production
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- A Teenage Girl with Unexpected Pubertal Changes
- Ayurvedic Management of Poly Cystic Ovarian Syndrome with Clinical and Biochemical Androgen Excess and Oligo-ovulation – A Case Study
- Novel progestogenic androgens for male contraception: design, synthesis, and activity of C7 α-substituted testosterone
- 892 Behavior of the two circulating androgens testosterone and DHEA and their main intracellular metabolites in an androgen-sensitive sebocyte cell line
- 013 Prostaglandin D2 enhances testosterone metabolism by ROS-mediated altered redox potential in keratinocytes
- Prevalence of androgenic alopecia (AGA) in patients with polycystic ovarian syndrome (PCOS) and characterization of associated clinical and biochemical features